ArticleEndocrine oncology (Bristol, England)2025
Validity of geographic-level social determinant of health metrics in pancreatic neuroendocrine tumors.
Article in Endocrine oncology (Bristol, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Various social determinants of health (SDOH) metrics, also known as area-based social measures, are utilized to evaluate access to cancer care and to explain disparities in outcomes. Little prior work has compared the validity of these various geographic metrics. We reviewed all patients surgically treated for PNETs (2006-2022) at a single comprehensive cancer center. We collected patient demographics including self-reported race (White or Black), billing addresses, tumor characteristics and area-based social measures. We then compared between- and within-race differences to understand accuracy across different geographic levels. One hundred seventy-nine patients were included; 49 (27%) Black, a median age of 60.3 years and 86 (48%) females. At the block group/census tract level, compared to White patients, Black patients lived in neighborhoods with lower educational attainment, lower income, higher rates of uninsurance, higher overall social vulnerability index (SVI), and higher area deprivation index (ADI) (all
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.